Thermo Fisher Scientific Other current assets increased by 2.5% to $2.68B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $2.39B to $2.68B. Over 5 years (FY 2020 to FY 2025), Other current assets shows an upward trend with a 18.2% CAGR.
Large, unexpected increases may warrant investigation into potential accounting adjustments or non-recurring items.
This is a catch-all category for current assets that do not fit into standard classifications like cash, receivables, or...
Standard across all industries; usually a minor component of the balance sheet.
current_assets_other_assets_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.33B | $1.43B | $1.64B | $1.59B | $1.65B | $1.74B | $1.64B | $1.77B | $1.72B | $1.70B | $1.76B | $1.90B | $2.03B | $1.91B | $1.96B | $2.39B | $2.60B | $2.47B | $2.61B | $2.68B |
| QoQ Change | — | +7.1% | +15.0% | -3.2% | +4.0% | +5.3% | -5.5% | +7.4% | -2.5% | -1.1% | +3.2% | +8.4% | +6.4% | -5.6% | +2.8% | +21.5% | +8.9% | -4.9% | +5.7% | +2.5% |
| YoY Change | — | — | — | — | +24.0% | +21.9% | +0.2% | +11.2% | +4.2% | -2.1% | +6.9% | +7.8% | +17.7% | +12.3% | +11.8% | +25.4% | +28.3% | +29.4% | +33.0% | +12.1% |